Normal View Dyslexic View

Comment on: Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
BJS Open, https://doi.org/10.1093/bjsopen/zrad135, published 24 January 2024
Dear Editor
We would like to commend Gwilym and colleagues for their commitment to amputation level shared decision-making. The PERCEIVE trial was a major undertaking requiring a large collaboration1.
One of their study goals was to validate existing amputation outcome prediction models and to compare model performance to clinicians’ ability to predict outcomes. While an intriguing comparison, this requires careful adherence to the methods used in the original studies. External validation is critical in facilitating the generalizability of models so that clinicians can apply them confidently to clinical settings. 
Unfortunately, there were several significant discrepancies between how the models were applied in the study versus in the model development. The most prominent concerns were the replication of predictors and outcomes. In the AMPREDICT Mobility and Reamputation models, it does not appear that the following predictors were included or measured as in the original models: functional independence, alcohol misuse, highest education level, and patient self-rated health. 
The AMPREDICT Mobility model predicted the Locomotor Capability Index-5 and the authors used the Special Interest Group in Amputee Medicine grades. These are very different measures; the LCI-5 includes a much more granular level of functional activities. The AMPREDICT model predicted 12-month outcomes among those who survived one year. The authors reported that 355 of their patients survived a year; however, 489 had mobility outcome data. It is unclear if this represents measurements taken before 12 months. For the reamputation outcome, it appears approximately 50% (190 of 355) had available data.  It is unclear what happened with the other 50% that survived.
We acknowledge the importance of this research.  However, unless the methods applied directly replicate the predictors and outcome measures, the interpretation of the results will be limited. Hopefully the work of these authors will encourage ongoing investigation addressing this challenging subject.
References

Related articles


Author response: Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study

Author response: Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study

Brenig Llwyd Gwilym1, Philip Pallmann2, Cherry-Ann Waldron2, Lucy Brookes-Howell2, Emma Thomas-Jones2, Christopher Twine3, Adrian Edwards2,4, David Charles Bosanquet1 on behalf of the PERCEIVE study group

1. South East Wales Vascular Network, Cardiff, UK
2. Centre for Trials Research, Cardiff University, Cardiff, UK
3. Bristol Centre for Surgical Research, Bristol Medical School, University of Bristol, Bristol, UK
4. Division of Population Medicine, Cardiff University, Cardiff, UK

Correspondence to: Brenig Llwyd Gwilym (email: brenig.gwilym@wales.nhs.uk)
Ward B2
University Hospital of Wales
Heath
Cardiff CF14 4XW
UK

DOI: https://doi.org/10.58974/bjss/azbc058

4 September 2024
Guest blog: Cerebral microbleeds following thoracic endovascular aortic repair

Guest blog: Cerebral microbleeds following thoracic endovascular aortic repair

W. Eilenberg a,b**, M. Bechstein d**, P. Charbonneauc, F. Rohlffs a, A. Eleshra a, G. Panuccio a, J. Bhangu b, J. Fiehler d, R. Greenhalgh e, S. Haulon c, T. Kölbel a* a German Aortic Center, Department of Vascular Medicine, University Heart & Vascular Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany b Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria c Centre de l’Aorte, Hôpital Marie Lannelongue, Groupe hospitalier Paris Saint Joseph, Université Paris Saclay, France d Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. e Vascular Surgical Research Group, Imperial College, London, UK. ** both authors contributed equally E-mail: wolf.eilenberg@meduniwien.ac.at

3 December 2021
Copied!